Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000–2002
Claudia Allemani(London Cancer), Alberto Ameijide(Institut de Recerca Biomèdica Catalunya Sud), Jaume Galcerán(Hospital Universitari Sant Joan de Reus), Pamela Minicozzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Franco Berrino(Tumori Foundation), Esther Bastiaannet(University of Zurich), Eva Ardanáz, Lucìa Mangone(Azienda Sanitaria Unità Locale di Reggio Emilia), Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Sabine Siesling(Netherlands Comprehensive Cancer Organisation), Anna Gavin(Queen's University Belfast), Antonio Navareño Mateos(Instituto de Investigación Biosanitaria de Granada), Guy Hédelin(Institut National de Recherche et de Sécurité), Andrea Micheli(Fondazione Bruno Kessler)
Cited by 80
Related Papers
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|The Breast|2022|3.3k
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
|JNCI Journal of the National Cancer Institute|2005|865
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650